SeaStar Medical Holding Co. (NASDAQ:ICU) Sees Large Decline in Short Interest

SeaStar Medical Holding Co. (NASDAQ:ICU) saw a large decline in short interest in the month of January. As of January 31st, there was short interest totalling 370,200 shares, a decline of 11.2% from the January 15th total of 416,700 shares. Based on an average daily volume of 460,800 shares, the days-to-cover ratio is currently 0.8 days. Currently, 5.4% of the company’s stock are short sold.

Institutional Investors Weigh In On SeaStar Medical

A hedge fund recently raised its stake in SeaStar Medical stock. Geode Capital Management LLC increased its position in shares of SeaStar Medical Holding Co. (NASDAQ:ICU) by 14.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 45,430 shares of the company’s stock after acquiring an additional 5,618 shares during the period. Geode Capital Management LLC owned about 1.02% of SeaStar Medical worth $88,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 1.69% of the company’s stock.

SeaStar Medical Stock Up 3.9 %

Shares of ICU traded up $0.07 during mid-day trading on Tuesday, reaching $1.86. The company’s stock had a trading volume of 177,272 shares, compared to its average volume of 619,444. The company has a market cap of $8.30 million, a price-to-earnings ratio of -0.16 and a beta of -1.02. The business has a fifty day moving average of $1.90 and a 200 day moving average of $3.39. SeaStar Medical has a 1 year low of $1.50 and a 1 year high of $42.92.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.